Princeton Capital Management Inc’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-44,250
| Closed | -$135K | – | 69 |
|
|
2016
Q4 | $135K | Sell |
44,250
-62,895
| -59% | -$192K | 0.09% | 63 |
|
|
2016
Q3 | $496K | Sell |
107,145
-17,250
| -14% | -$79.9K | 0.32% | 55 |
|
|
2016
Q2 | $720K | Hold |
124,395
| – | – | 0.5% | 45 |
|
|
2016
Q1 | $753K | Sell |
124,395
-3,000
| -2% | -$18.2K | 0.52% | 44 |
|
|
2015
Q4 | $1.16M | Buy |
127,395
+5,950
| +5% | +$54.3K | 0.82% | 38 |
|
|
2015
Q3 | $685K | Buy |
121,445
+7,325
| +6% | +$41.3K | 0.41% | 44 |
|
|
2015
Q2 | $1.27M | Hold |
114,120
| – | – | 0.67% | 39 |
|
|
2015
Q1 | $1.79M | Buy |
114,120
+1,580
| +1% | +$24.8K | 0.92% | 37 |
|
|
2014
Q4 | $1.71M | Buy |
112,540
+9,775
| +10% | +$149K | 0.95% | 38 |
|
|
2014
Q3 | $1.11M | Buy |
102,765
+4,000
| +4% | +$43.1K | 0.71% | 42 |
|
|
2014
Q2 | $1.51M | Buy |
98,765
+22,815
| +30% | +$348K | 1.04% | 36 |
|
|
2014
Q1 | $1.37M | Buy |
75,950
+13,700
| +22% | +$248K | 1% | 37 |
|
|
2013
Q4 | $865K | Sell |
62,250
-4,700
| -7% | -$65.3K | 0.69% | 45 |
|
|
2013
Q3 | $702K | Buy |
66,950
+50,450
| +306% | +$529K | 0.64% | 44 |
|
|
2013
Q2 | $129K | Buy |
+16,500
| New | +$129K | 0.12% | 68 |
|